Michał Abram

12PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsGene expression (incl. microarray and other genome-wide approaches)Biologically active moleculesCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 29, 2026
Second-Generation of Deuterium-Substituted Glutamate Uptake Enhancers Exhibit Superior Drug-Like Properties in Preclinical Evaluation.

|May 01, 2026
Novel 3-Methoxypropanamide Derivatives as Potential Antiseizure and Antinociceptive Agents: Experimental Evidence from In Vitro and In Vivo Studies.

|Feb 27, 2025
Effect of SSR504734, a Selective Glycine Transporter Type 1 Inhibitor, on Seizure Thresholds, Neurotransmitter Levels, and Inflammatory Markers in Mice.

Nikola Gapińska, Piotr Wlaź, Elżbieta Wyska

|Sep 28, 2024
Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models.

Michał Abram, Marcin Jakubiec, Paulina Koczurkiewicz-Adamczyk

|Aug 21, 2024
Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.

Marcin Jakubiec, Michał Abram, Mirosław Zagaja

|May 14, 2024
Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.

Marcin Jakubiec, Michał Abram, Mirosław Zagaja

Pageof 2

Frequent Collaborators

12 joint publications

Krzysztof Kamiński

6 joint publications

Katarzyna Socała

6 joint publications

Piotr Wlaź

4 joint publications

Marcin Jakubiec